Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics of omadacycline (PTK 0796) in subjects with hepatic impairment.

Trial Profile

Pharmacokinetics of omadacycline (PTK 0796) in subjects with hepatic impairment.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2012

At a glance

  • Drugs Omadacycline (Primary) ; Omadacycline (Primary)
  • Indications Bacterial infections; Community-acquired pneumonia; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors Novartis Pharmaceuticals; Paratek Pharmaceuticals
  • Most Recent Events

    • 24 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top